Fluidigm (LAB): Earnings per share for the last twelve months
Standard BioTools Inc. (LAB) maintains stability through patent-protected cell analysis methods that create customer lock-in to the platform. This TTM earnings per share chart demonstrates the current balance of power among major players, where the value -0.18 captures the metric level. Revenue is based on the sale of consumables for expensive equipment, while high margins are achieved by scaling the mass production of instruments.
Summary analytical data breakdowns for Standard BioTools Inc (LAB)
- stock price and consensus target price:
- stock exchange capitalization data:
- shareholders' equity book value data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Standard BioTools Inc.|LAB - Long-Term Debt to Capital|Short-Term Debt to Equity Fluidigm|LAB - Company Aggregate Debt|Debts to Book Capitalization Standard BioTools Inc.|LAB - Company Long-Term Indebtedness|Company Short-Term Debts Standard BioTools|Quick Liquidity fluidigm.com
- earnings and multiples data:
LAB - Final Profit|Projected Future Earnings Standard BioTools Inc.|LAB - Price to Earnings Multiple|Projected Price to Earnings Standard BioTools|LAB - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Standard BioTools Inc.|LAB - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Standard BioTools|LAB - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months fluidigm.com|LAB - Earnings per share growth rate in current year|Expected earnings per share growth for next year Standard BioTools Inc.
Fundamental valuation:Standard BioTools Inc. (LAB)
Net income per share (TTM) consolidates the business's total annual income, distributing it across each security to determine the actual return on equity. By analyzing changes in TTM net income per share, an investor assesses the efficiency of Standard BioTools Inc. (LAB) biopharmaceutical equipment manufacturing plants in the US and its global research centers.
Direct competitors
Agilent Technologies - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters questdiagnostics.com DGX|Illumina (ILMN) - Earnings per share for the last twelve months|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp (BIO) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months NNNN (Anbio Biotechnology)|Earnings per share for the last four quarters SHC|Net earnings per share (EPS TTM) QDEL (QuidelOrtho Corporation)|Net earnings per share (EPS TTM) OPKO Health Inc OPK|CDNA - Earnings per share for the last twelve months|MRVI (Maravai) - Earnings per share for the last 12 months|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CTKB|OSUR (OraSure) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Exagen Diagnostics|Earnings per share for the last twelve months MDxHealth Inc. (MDXH)|LUCD (Lucid Diagnostics, Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRE (Prenetics)|IMDX: Earnings per share for the last 12 months|TRIB: Net earnings per share for the last 12 months|Earnings per share for the trailing year PRPH (ProPhase Labs Inc)|AIMD: Net earnings per share (EPS TTM)|CODX (CoDx) - Earnings per share for the last twelve months|HSCS (Heart Test Laboratories) - Net earnings per share (EPS TTM)|biomerica.com (BMRA) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cardio Diagnostics (CDIO)|ONCO - Net earnings per one share for the last twelve months|Virax Biolabs Group Ltd - Net earnings per share for the last 12 months|Earnings per share for the last four quarters BJDX (Bluejay Diagnostics Corp)|AWH - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months acceleratediagnostics.com|Centogene N.V. (CNTG) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Enzo Biochem (ENZ)|Earnings per share for the last twelve months Fresh2 Group Ltd|Earnings per share for the last twelve months GENE|Earnings per share for the last twelve months 23andMe Holding Co. (ME)|Net earnings per share for the last four quarters psychemedics.com
